Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Mass Spectrometry Instrument Setup – V 2.0

Posted on By

BA-BE Studies: SOP for Mass Spectrometry Instrument Setup – V 2.0

Standard Operating Procedure for Mass Spectrometry Instrument Setup in BA/BE Bioanalytical Laboratories

Department BA-BE Studies
SOP No. SOP/BA-BE/161/2025
Supersedes SOP/BA-BE/161/2022
Page No. Page 1 of 10
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To provide a validated and standardized procedure for setting up mass spectrometry instruments (e.g., triple quadrupole LC-MS/MS systems) for bioanalytical applications in BA/BE studies.

2. Scope

This SOP applies to all laboratory analysts and instrumentation personnel responsible for preparing and configuring mass spectrometry instruments for validated bioanalytical runs.

3. Responsibilities

  • Analyst: Performs instrument setup, checks readiness, and executes system suitability.
  • Lab Manager: Verifies
setup, logs performance, and ensures timely maintenance.
  • QA: Ensures all records of system setup and configuration are reviewed for compliance.
  • 4. Accountability

    The Head of Bioanalytical Lab is accountable for ensuring mass spectrometers are properly set up, verified, and maintained in alignment with regulatory and quality standards.

    5. Procedure

    5.1 Pre-Setup Checklist

    1. Ensure the instrument has completed its regular maintenance schedule (check maintenance log).
    2. Confirm environmental controls (room temperature 20–25°C, humidity 40–60%) are within limits.
    3. Check nitrogen gas supply, pump oil levels, and voltage supply (UPS backup status).

    5.2 Power-Up Sequence

    1. Turn on the roughing pump and allow stabilization (5–10 minutes).
    2. Switch on the mass spectrometer’s main power and ion source heater.
    3. Activate source gases (Nebulizer, Curtain, Ion Spray) per instrument specs.

    5.3 LC Integration and System Connection

    1. Connect LC flow path (from column outlet) to MS ionization source (e.g., ESI probe).
    2. Check that there are no leaks or blockages in capillaries and ferrules.
    3. Ensure the autosampler and pump are calibrated and set to desired flow rate (e.g., 0.5 mL/min).

    5.4 Ion Source Configuration

    1. Select appropriate ion source: Electrospray Ionization (ESI) or Atmospheric Pressure Chemical Ionization (APCI).
    2. Adjust parameters:
      • Ion Spray Voltage: 4000–5500 V (ESI)
      • Source Temperature: 400–500°C
      • Curtain Gas: 25 psi
      • Nebulizer Gas: 50 psi
    3. Load method file with predefined compound parameters (from validation protocol).

    5.5 Calibration and Tuning

    1. Infuse tuning solution (e.g., PPG, reserpine) using a syringe pump.
    2. Perform mass calibration using standard ions:
      • Low Mass: 118.1 m/z
      • Mid Mass: 622.0 m/z
      • High Mass: 1222.0 m/z
    3. Check peak intensity, resolution, and mass accuracy < ±0.1 Da.
    4. Save calibration and tuning results in Annexure-1: MS Setup Log.

    5.6 System Suitability Test (SST)

    1. Inject system suitability standard (SSS) under validated LC-MS/MS conditions.
    2. Verify:
      • Peak area RSD < 5%
      • Retention time within ±2%
      • S/N ratio meets minimum acceptance criteria
    3. If SST fails, investigate and document in Annexure-2: SST Deviation Log.

    5.7 Data File Management

    1. Assign unique file path and batch name for each sequence.
    2. Ensure raw data are automatically saved in designated secure directories.
    3. Backup data on a daily basis to validated storage media/server.

    5.8 Shutdown Procedure (if not in use)

    1. Stop LC flow and flush system with water/acetonitrile mixture.
    2. Switch off ion source gases and power down MS components in reverse sequence.
    3. Log off software and note instrument status on Annexure-3: Instrument Status Record.

    6. Abbreviations

    • BA/BE: Bioavailability/Bioequivalence
    • MS: Mass Spectrometry
    • LC: Liquid Chromatography
    • ESI: Electrospray Ionization
    • SST: System Suitability Test

    7. Documents

    1. MS Setup Log – Annexure-1
    2. SST Deviation Log – Annexure-2
    3. Instrument Status Record – Annexure-3

    8. References

    • ICH M10: Bioanalytical Method Validation
    • Instrument Operating Manual (e.g., SCIEX, Agilent, Thermo)
    • FDA Guidance for Industry: Bioanalytical Method Validation

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: MS Setup Log

    Date Instrument ID Ion Source Tuning Compound Setup By
    17/04/2025 MS-003 ESI PPG Sunita Reddy

    Annexure-2: SST Deviation Log

    Date Run ID Issue Observed Corrective Action Reviewed By
    17/04/2025 BE-MS-101 Low S/N ratio Re-tuned ion source Rajesh Kumar

    Annexure-3: Instrument Status Record

    Date Status Comment Logged By
    17/04/2025 Standby Awaiting next batch Vinay Pawar

    Revision History:

    Revision Date Revision No. Details Reason Approved By
    01/01/2022 1.0 Initial release New SOP QA Head
    17/04/2025 2.0 Expanded shutdown sequence and calibration standards Audit Compliance QA Head
    See also  BA-BE Studies: SOP for Observing Post-Dose Adverse Events - V 2.0
    BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

    Post navigation

    Previous Post: API Manufacturing: SOP for Calibration and Maintenance of pH Meter – V 2.0
    Next Post: Biosimilars: SOP for In-Process pH Drift Correction in Bioreactor Operations – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version